Valuation: Cutia Therapeutics

Market Cap 676M 789M 101M 86.08M 80.32M 73.7M 138M 9.62B 141M 953M 371M 4.82B 378M 369M 15.96B P/E 2026 *
-4.06x
P/E 2027 * 14.3x
Enterprise Value 745M 869M 111M 94.83M 88.48M 81.18M 153M 10.6B 156M 1.05B 409M 5.31B 416M 407M 17.58B EV / Sales 2026 *
1.15x
EV / Sales 2027 * 0.57x
Free-Float
32.66%
Yield 2026 *
-
Yield 2027 * -
1 day-10.14%
1 week-12.56%
Current month-16.67%
1 month-25.29%
3 months-52.67%
6 months-60.45%
Current year-57.05%
1 week 1.9
Extreme 1.9
2.3
1 month 1.9
Extreme 1.9
2.68
Current year 1.9
Extreme 1.9
5.51
1 year 1.9
Extreme 1.9
12
3 years 1.9
Extreme 1.9
31
5 years 1.9
Extreme 1.9
32.6
10 years 1.9
Extreme 1.9
32.6
Manager TitleAgeSince
Chief Executive Officer 48 2019-08-31
Director of Finance/CFO 36 2021-05-09
Chief Tech/Sci/R&D Officer 42 2020-01-09
Director TitleAgeSince
Director/Board Member 48 2020-05-11
Chairman 63 2019-08-22
Director/Board Member 36 2022-11-14
Date Insider Type Main position Quantity % Market Cap.
10/15/24 Other

Founder

15,000 0.0049%
10/3/24 Other

Chief Financial Officer

20,000 0.0066%
10/2/24 Other

Chief Financial Officer

30,000 0.0098%
Change 5-day change 1-year change 3-year change Capi.($)
-10.14%-12.56%-79.54%-92.12% 101M
-2.81%+2.93%+76.40%+127.73% 1,109B
-2.21%+2.02%+49.50%+55.01% 644B
-1.56%+4.39%+25.19%+74.39% 463B
-1.43%+3.24%+39.66%+44.16% 371B
-1.09%+2.06%+21.49%+38.84% 301B
-0.73%+4.74%-0.37%+12.45% 256B
-1.95%+3.80%+46.31%+65.66% 234B
-0.55%-0.02%-17.26%-53.27% 205B
-2.82%+3.84%+20.81%+89.04% 178B
Average -1.79%+2.06%+18.22%+36.19% 376.12B
Weighted average by Cap. -0.69%+3.26%+42.65%+69.96%

Financials

2026 *2027 *
Net sales 646M 753M 96.03M 82.22M 76.71M 70.39M 132M 9.19B 135M 910M 355M 4.6B 361M 353M 15.24B 1.18B 1.38B 175M 150M 140M 129M 242M 16.78B 246M 1.66B 648M 8.41B 659M 644M 27.85B
Net income -146M -170M -21.67M -18.55M -17.31M -15.88M -29.84M -2.07B -30.43M -205M -80.04M -1.04B -81.35M -79.58M -3.44B 44.25M 51.59M 6.58M 5.63M 5.26M 4.82M 9.06M 629M 9.24M 62.34M 24.3M 315M 24.7M 24.16M 1.04B
Net Debt 68.7M 80.1M 10.21M 8.75M 8.16M 7.49M 14.07M 977M 14.35M 96.8M 37.73M 490M 38.35M 37.52M 1.62B -
Logo Cutia Therapeutics
Cutia Therapeutics is an investment holding company principally engaged in the dermatology biopharmaceutical business. The Company is dedicated to developing solutions in the dermatology treatment and care market, including scalp diseases and care, skin diseases and care, topical anesthesia and localized adipose accumulation management. The Company is primarily engaged in the distribution of scalp diseases and care products, as well as certain skin care products. The Company's principal pipeline products include topical finasteride spray CU-40102, topical 4% minocycline foam CU-10201, topical novel small molecule agent CU-10101, localized topical lidocaine and tetracaine cream CU-30101 and recombinant mutant collagenase CU-20401.
Employees
-
Date Price Change Volume
26-08-21 HK$1.950 -10.14% 633,400
26-08-20 HK$2.170 +0.46% 91,000
26-08-19 HK$2.160 -1.37% 116,000
26-08-18 HK$2.190 -1.79% 58,800
26-08-17 HK$2.230 0.00% 62,800
Trader
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
1.861CNY
Average target price
9.801CNY
Spread / Average Target
+426.65%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 2487 Stock